VAERS Reports U006486

VAERS 2528343

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

mild

Staat: MI
Alter: 4,0
Geschlecht: F
Eingang: 09.12.2022
Impfdatum: 21.10.2021
Beginn: 22.10.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SC / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Erythema Urticaria

Symptomtext

Pt. had redness around the nape of her neck and her ears earlier the morning following the vaccinations. No other symptoms at that time, 6 hours later I have noticed hives. A few on her neck and some on her lower back. I gave her Benadryl at 8:30 Friday ( day after vaccine) night and she was rash free the next morning but then around 3:30pm it came back and it was odd because it was red almost opposite of where it was red the day before. It appeared to me to look like a chemical burn from the inside out. I would like to share photos if able.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urticaria
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2206643

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

mild

Staat: TN
Alter: 4,0
Geschlecht: F
Eingang: 30.03.2022
Impfdatum: 29.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SC / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site rash Rash erythematous Rash macular

Symptomtext

Erythematous macular rash 3 cm by 1 cm around injection site

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2155051

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

mild

Staat: GA
Alter: 4,0
Geschlecht: F
Eingang: 03.03.2022
Impfdatum: 23.02.2022
Beginn: 02.03.2022
Tage bis Beginn: 7,0
Dosis: 2
Route/Site: SC / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Pruritus Rash papular Rash pruritic Urticaria

Symptomtext

3/2/2022 around 8pm started to complain of feeling itchy around her neck - progressed to hives - woke up at midnight with itchy raised rash. Have benadryl at 8:30am 3/3/2022 and rash started to fade.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Gastrointestinal virus 1/31/2022
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1959264

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

mild

Staat: MI
Alter: 9,0
Geschlecht: M
Eingang: 17.12.2021
Impfdatum: 13.12.2021
Beginn: 14.12.2021
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Erythema Pain Swelling

Symptomtext

5cm x 3cm erythematous, swollen sore area developed within 24 hours of vaccination

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: tree nut allergy
Andere Medikamente: None
Allergien: Tree nut
Vorherige Impfungen: -

VAERS 2608010

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

gering

Staat: TX
Alter: -
Geschlecht: U
Eingang: 03.04.2023
Impfdatum: 02.03.2023
Beginn: 02.03.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Caller reported expired dose of MMR II was administered. No other information provided. No additional AEs or PQC reported.; This spontaneous report was received from a certified medical assistant, and refers to a patient of unspecified age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 02-MAR-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #U006486, administered subcutaneously in the left tight, for prophylaxis (strength was not provided). The dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) expired on 26-FEB-2023. No adverse events were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2606938

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

gering

Staat: TX
Alter: -
Geschlecht: U
Eingang: 31.03.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

HCP calling to report administration of expired MMR-II vaccine and requesting information regarding stability after expiration.; No additional AE; This spontaneous report was received from a nurse prescriber and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHA) (M-M-R II) subcutaneous injection, 0.5 milliliter/once, lot #U006486, expiration date: 26-FEB-2023, administered for prophylaxis (anatomical location, and route of administration were not provided) (expired product administered). The reporter requested information regarding stability after expiration. It was reported that there were no temperature excursions to product. There were no adverse events reported (no adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2592365

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u006486

gering

Staat: TN
Alter: 1,0
Geschlecht: M
Eingang: 07.03.2023
Impfdatum: 07.03.2023
Beginn: 07.03.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

Gave vaccine to pt and realized after I was going to chart it that it was expired. 2/26/2023 was the expiration date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: ear infection
Vorgeschichte: iron deficiency anemia
Andere Medikamente: ferrous sulfate 15mg/mL oral drops PO BID
Allergien: n/a
Vorherige Impfungen: -

VAERS 2454207

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

gering

Staat: AR
Alter: 0,2
Geschlecht: F
Eingang: 28.09.2022
Impfdatum: 13.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

No additional AE reported; Customer reported that MMR II and VARIVAX were administered to a 2 month old baby in error today (09/13/2022). Patient was not due for these vaccines until she was 12 months; This spontaneous report has been received from a nurse concerning a 2-month-old female patient. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported. On 13-SEP-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II), 0.5 milliliter (ml) (lot # U006486, has been verified to be a valid lot number for measles, mumps, and rubella [wistar ra 27-3] virus vaccine, live [rHA] [M-M-R II], expiration date reported and upon internal validation established as 26-FEB-2023) (anatomical location and route of administration were not reported) and varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U032852, has been verified to be a valid lot number for varicella virus vaccine live [oka/merck] [VARIVAX], expiration date reported and upon internal validation established as 20-OCT-2023) (anatomical location and route of administration were not reported). Both vaccines were given as prophylaxis. The patient was not due for these vaccines until she was 12 months old (Product administered to patient of inappropriate age). No adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2454207

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

gering

Staat: AR
Alter: 0,2
Geschlecht: F
Eingang: 28.09.2022
Impfdatum: 13.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

No additional AE reported; Customer reported that MMR II and VARIVAX were administered to a 2 month old baby in error today (09/13/2022). Patient was not due for these vaccines until she was 12 months; This spontaneous report has been received from a nurse concerning a 2-month-old female patient. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported. On 13-SEP-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II), 0.5 milliliter (ml) (lot # U006486, has been verified to be a valid lot number for measles, mumps, and rubella [wistar ra 27-3] virus vaccine, live [rHA] [M-M-R II], expiration date reported and upon internal validation established as 26-FEB-2023) (anatomical location and route of administration were not reported) and varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U032852, has been verified to be a valid lot number for varicella virus vaccine live [oka/merck] [VARIVAX], expiration date reported and upon internal validation established as 20-OCT-2023) (anatomical location and route of administration were not reported). Both vaccines were given as prophylaxis. The patient was not due for these vaccines until she was 12 months old (Product administered to patient of inappropriate age). No adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2429178

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

gering

Staat: MS
Alter: 19,0
Geschlecht: U
Eingang: 06.09.2022
Impfdatum: 19.08.2022
Beginn: 25.08.2022
Tage bis Beginn: 6,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration No adverse event Product administered to patient of inappropriate age

Symptomtext

The patient had no adverse side effects at time of call.; Pharmacist called asking for recommendations after it was discovered that two live vaccines were administered less than 28 days apart. Pharmacist states that a 19 year old patient needed VARIVAX and MMR-II for school purposes.; a 19 year old patient needed MMR-II; This spontaneous report was received from pharmacist and refers to a 19-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 19-AUG-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter subcutaneously, lot #T035400, expiration date: 16-OCT-2022 for prophylaxis. On 25-AUG-2022, less than 28 days from another live vaccine, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter subcutaneously, albumin status of recombinant human albumin (rHA) lot #U006486, expiration date: 26-FEB-2023 for prophylaxis (inappropriate schedule of product administration, product administered to patient of inappropriate age). The patient had no adverse side effects at time of call.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2371321

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

gering

Staat: FL
Alter: -
Geschlecht: U
Eingang: 16.07.2022
Impfdatum: -
Beginn: 24.06.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product storage error

Symptomtext

No additional AE details provided.; Nurse calling in to report an AE for a patient that received MMR-II that was improperly stored. No additional AE details provided. No PQC. Names of vaccines involved (including lot/exp): MMR-II (U006486 2/26/2023; U019290 6/18/2023) Temperature; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (albumin status rHA) (M-M-R II) 5 milliliter, subcutaneously, lot# U006486, expiration date 26-FEB-2023 (dose number and vaccination schedule were not provided) for prophylaxis. This vaccine and the other vaccine measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (albumin status rHA) (M-M-R II) lot#U019290, expiration date 18-JUN-2023 had been improperly stored in the temperature of 61.5 Fahrenheit degrees (F) for 9 hours 20 minutes with no previous temperature excursion (product storage error). It was unknown if digital data logger was involved. No additional adverse events were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2240376

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

gering

Staat: MS
Alter: -
Geschlecht: U
Eingang: 19.04.2022
Impfdatum: 23.03.2022
Beginn: 23.03.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration

Symptomtext

Administration of MMR and VARIVAX intramuscularly; This spontaneous report was received from a physician's assistant concerning a patient of unspecified age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 23-MAR-2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot # U029496, expiration date: 21-SEP-2023, administered intramuscularly (unapproved route) as prophylaxis (strength, was not provided); and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #U006486, expiration date: 26-FEB-2023, administered intramuscularly (unapproved route) as prophylaxis (strength was not provided).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2226081

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006486

gering

Staat: SC
Alter: -
Geschlecht: M
Eingang: 11.04.2022
Impfdatum: 04.04.2022
Beginn: 04.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

Male patient recruits at the Clinic, were given expired Pfizer vaccine with the lot number FF2587. The original expiration date was DEC 2021 and was extended 90 days to MAR 2022. The Pfizer was 4 days past the expiration date when given. No adverse signs and symptoms noted, appropriated providers notified. Patients are currently being monitored for any other reactions. Pfizer has data to support stability of the lot number FF2587 through JUNE 2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: NA
Allergien: NA
Vorherige Impfungen: -